Please login to the form below

Not currently logged in
Email:
Password:

infectious diseases

This page shows the latest infectious diseases news and features for those working in and with pharma, biotech and healthcare.

Sanofi taps Evotec for new anti-infectives drive

Sanofi taps Evotec for new anti-infectives drive

Sanofi is in advanced negotiations with German biotech Evotec about setting up a new open innovation platform to develop new drugs for infectious diseases, according to the two companies. ... Sanofi has a long and established history in the fight against

Latest news

More from news
Approximately 3 fully matching, plus 176 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    A study recently reported in The Lancet Infectious Diseases found that antibiotics are now failing to work in a fifth of patients who suffer an infection after hospital surgery.

  • Reading human behaviour to create a medical future Reading human behaviour to create a medical future

    that require degrees of self-management, whereas 100 years ago it was an infectious disease world where patient involvement and input was minimal. ... Behavioural science is not a strong part of medical training, which is largely still grounded in

  • Deal Watch February 2016 Deal Watch February 2016

    Alere has annual sales of approximately $2.5bn from a portfolio of point-of-care products in areas including cardiometabolic, infectious diseases such as HIV, malaria, syphilis, E. ... Pronutria's focus is on the development of therapeutics and

  • Searching for health Searching for health

    year. The pharma work is organised into therapeutic areas covering cancers, infectious diseases, immunology, cardiovascular and metabolism diseases with each having dedicated research teams managing all aspects - from finding new compounds

  • The world is our laboratory The world is our laboratory

    Our goal is to improve patient outcomes in the most serious unmet medical needs of our time, including neglected diseases. ... Focused specialties. At Janssen, we have focused our research into five important therapeutic areas: Cardiovascular &Metabolic

More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest appointments

  • Nabriva Therapeutics appoints chief medical officer Nabriva Therapeutics appoints chief medical officer

    Commenting on the appointment, Dr Colin Broom, chief executive officer of Nabriva, said: “Jennifer has broad expertise in infectious diseases and internal medicine with extensive experience in both clinical development and

  • Dr Jan van de Winkel joins Austrian biotech Hookipa Dr Jan van de Winkel joins Austrian biotech Hookipa

    As Hookipa grows and progresses to become an integrated biotech company with multiple clinical programmes in infectious diseases and immune-oncology, Jan’s experience of building companies and his scientific insight

  • Emotive expands client services team Emotive expands client services team

    Biology graduate Rob Mackichan joins the agency as an account manager, bringing experience of working with infectious diseases, rare diseases and medical devices.

  • emotive boosts its client services team emotive boosts its client services team

    Joining as a senior account director, Andy Parry has 9 years’experience in healthcare communications and has worked on global brands in CNS, infectious diseases, respiratory and rare disease.

  • Polyphor appoints new chief medical and development officer Polyphor appoints new chief medical and development officer

    Dr Baker arrives at Polyphor from Novartis, where she held several positions including global head of medical affairs, development head for infectious diseases, transplants and immunology, and global head of clinical

More from appointments
Approximately 0 fully matching, plus 34 partially matching documents found.

Latest from PMHub

  • To track disease, follow the money

    Contrast this with the slow march of infectious diseases before the era of mass movement and jet travel. ... But banknotes do not spread or reproduce like infectious agents, more's the pity, nor does the movement of money accurately reproduce the

  • emotive. expands client services team

    as an Account Manager. A Biology graduate from the University of Leeds, Rob has experience working in infectious diseases, rare diseases and medical devices, amongst other therapy areas.

  • A fast-growing client services team at emotive.

    Starting his career in Medical Education and then moving into healthcare advertising, Andy has worked on large global brands in CNS, infectious diseases, respiratory and rare diseases.

  • emotive. expands Medical Writing and Client Services teams

    With over 9 years’ experience in medical communications, Aki Okazaki who is joining as an Associate Director, has worked in a broad range of therapeutic areas including haematology, infectious diseases, oncology, ... psychiatric conditions, rare

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics